<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - 05/10/2024</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Progress note - 05/10/2024</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">PELAT AARON</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">September 4, 1934 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Female</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Black or African American</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Not Hispanic or Latino</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Postal Address:<br/>19520 NW 37TH AVENUE<br/>MIAMI GARDENS, FL 33056, US<br/><br/>Primary Home Phone:  305-522-8974<br/>Mobile Phone:  305-522-8974<br/>Email:  darrylvaaron@gmail.com<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">71937 2.16.840.1.113883.4.391.329324<br/>71937 2.16.840.1.113883.4.391.329324.1<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">748e250c-742c-4366-baf1-63f3897babd9 2.16.840.1.113883.4.391</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">August 15, 2024, 13:25:27 -0400 </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">GLENDA BUYO</td></tr><tr><td class="td_header_role_value internal_format">1806 N PINE ISLAND RD<br/>PLANTATION, FL 33322-5202, US<br/><br/>Tel:  954-474-0110<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">eClinicalWorks</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">1325217 2.16.840.1.113883.4.391.329324</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">ambulatory</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From May 10, 2024, 08:40:00   to May 10, 2024, 09:00:00  </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">id:  2.16.840.1.113883.4.391.329324</td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">GLENDA BUYO</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">1806 N PINE ISLAND RD<br/>PLANTATION, FL 33322-5202, US<br/><br/>Tel:  954-474-0110<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Emergency contact</span></td><td class="td_header_role_value">DARRYL AARON<br/><br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">19520 NW 37TH AVENUE<br/>MIAMI GARDENS, FL 33056, US<br/><br/>Tel:  305-522-8974<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Guarantor</span></td><td class="td_header_role_value">PELAT AARON<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  305-522-8974<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value">GLENDA BUYO signed at May 10, 2024 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">1806 N PINE ISLAND RD<br/>PLANTATION, FL 33322-5202, US<br/><br/>Tel:  954-474-0110<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">ClareMedica Corporate SDPC</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">14750 NW 77th court suite 100<br/>MIAMI LAKES, FL 330161507, US<br/><br/>Tel:  786-485-1005<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">ALLERGIES</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">MEDICATIONS</a></li><li><a href="#id4">SOCIAL HISTORY</a></li><li><a href="#id5">PROBLEMS</a></li><li><a href="#id6">VITAL SIGNS</a></li><li><a href="#id7">Encounters</a></li><li><a href="#id8">ASSESSMENTS</a></li><li><a href="#id9">PLAN OF TREATMENT</a></li><li><a href="#id10">Progress Notes</a></li><li><a href="#id11">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">ALLERGIES</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>PT. FOLLOW UP</div><h3><a name="id3" href="#toc">MEDICATIONS</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Atorvastatin Calcium 20 MG</td><td ID="instruction1">1 tablet once a day for 90 days Oral Once a day for 90 days</td><td/><td>11/14/2023</td><td/><td>Active</td></tr><tr><td ID="medication2">Vitamin D3 1.25 MG (50000 UT)</td><td ID="instruction2">1 capsule Orally once a week for 90 days</td><td/><td>04/04/2024</td><td>07/03/2024</td><td>Active</td></tr><tr><td ID="medication3">Lisinopril 20 MG</td><td ID="instruction3">1 tablet Orally Once a day for 90 days</td><td/><td>11/14/2023</td><td/><td>Active</td></tr><tr><td ID="medication4">metFORMIN HCl 500 MG</td><td ID="instruction4">1 tablet with a meal Orally twice a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">Montelukast Sodium 10 MG</td><td ID="instruction5">1 tablet Orally Once a day for 30 days</td><td/><td>05/10/2024</td><td/><td>Active</td></tr><tr><td ID="medication6">hydroCHLOROthiazide 12.5 MG</td><td ID="instruction6">TAKE 1 CAPSULE BY MOUTH EVERY DAY IN THE MORNING for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">Eliquis 5 MG</td><td ID="instruction7">TAKE 1 TABLET BY MOUTH TWICE DAILY for 90</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id4" href="#toc">SOCIAL HISTORY</a></h3><div><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Unknown</td></tr></tbody></table><span class="content_span">Alcohol Screen (Audit-C)</span><table width="100%" border="1"><thead><tr><th>Question</th><th>Answer</th><th>Notes</th></tr></thead><tbody><tr><td>Did you have a drink containing alcohol in the past year?</td><td>No</td><td/></tr><tr><td>Points</td><td>0</td><td/></tr><tr><td>Interpretation</td><td>Negative</td><td/></tr></tbody></table></div><h3><a name="id5" href="#toc">PROBLEMS</a></h3><div><table width="100%" border="1"><thead><tr><th>Problem Type</th><th>ICD Code</th><th>Onset Dates</th><th>Problem Status</th><th>W/U Status</th><th>Risk</th><th>SNOMED Code</th><th>Notes</th></tr></thead><tbody><tr><td>Problem</td><td ID="Problem1">Type 2 diabetes mellitus with hyperglycemia (E11.65)</td><td/><td>Active</td><td>confirmed</td><td/><td>237599002</td><td/></tr><tr><td>Problem</td><td ID="Problem2">Long term (current) use of insulin (Z79.4)</td><td/><td>Active</td><td>confirmed</td><td/><td>710815001</td><td/></tr><tr><td>Problem</td><td ID="Problem3">Seasonal allergic rhinitis due to pollen (J30.1)</td><td/><td>Active</td><td>confirmed</td><td/><td>21719001</td><td/></tr><tr><td>Problem</td><td ID="Problem4">Stage 3b chronic kidney disease (N18.32)</td><td/><td>Active</td><td>confirmed</td><td/><td>700379002</td><td/></tr><tr><td>Problem</td><td ID="Problem5">Type 2 diabetes mellitus with diabetic chronic kidney disease (E11.22)</td><td/><td>Active</td><td>confirmed</td><td/><td>Diabetic renal disease (127013003)</td><td/></tr><tr><td>Problem</td><td ID="Problem6">Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or chronic kidney disease (I13.0)</td><td/><td>Active</td><td>confirmed</td><td/><td>Hypertensive heart AND chronic kidney disease with congestive heart failure (15781000119107)</td><td/></tr><tr><td>Problem</td><td ID="Problem7">Chronic obstructive pulmonary disease, unspecified (J44.9)</td><td/><td>Active</td><td>confirmed</td><td/><td>Chronic obstructive pulmonary disease (13645005)</td><td/></tr></tbody></table></div><h3><a name="id6" href="#toc">VITAL SIGNS</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Temperature</th><td>97.2 degrees Fahrenheit</td><td>05/10/2024</td></tr><tr><th ID="vital2">Blood pressure systolic</th><td>130 mm Hg</td><td>05/10/2024</td></tr><tr><th ID="vital3">Blood pressure diastolic</th><td>90 mm Hg</td><td>05/10/2024</td></tr><tr><th ID="vital4">Heart Rate</th><td>93 /min</td><td>05/10/2024</td></tr><tr><th ID="vital5">Respiratory Rate</th><td>18 /min</td><td>05/10/2024</td></tr><tr><th ID="vital6">Height</th><td>63 in</td><td>05/10/2024</td></tr><tr><th ID="vital7">Oximetry</th><td>99 %</td><td>05/10/2024</td></tr><tr><th ID="vital8">Height-cm</th><td>160.02 cm</td><td>05/10/2024</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>ClareMedica of Plantation</td><td>1806 N PINE ISLAND RD PLANTATION, FL 33322-5202</td><td>05/10/2024</td><td>GLENDA BUYO</td><td>Type 2 diabetes mellitus with diabetic polyneuropathy E11.42 ; Type 2 diabetes mellitus with hyperglycemia E11.65 ; Hyperlipidemia, unspecified E78.5 ; Chronic pulmonary embolism I27.82 ; Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or chronic kidney disease I13.0 ; Stage 3b chronic kidney disease N18.32 ; Acute on chronic right heart failure I50.813 ; Type 2 diabetes mellitus with diabetic chronic kidney disease E11.22 and Seasonal allergic rhinitis due to pollen J30.1</td></tr></tbody></table></div><h3><a name="id8" href="#toc">ASSESSMENTS</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">05/10/2024</td><td>Type 2 diabetes mellitus with diabetic polyneuropathy (ICD-10 - E11.42)</td><td/><td>Continue current medications. Check HgbA1C every 3 months. Encourage ADA, low carb diet and daily exercise. Eye and foot care reviewed.</td><td/></tr><tr><td ID="ref2">05/10/2024</td><td>Type 2 diabetes mellitus with hyperglycemia (ICD-10 - E11.65)</td><td/><td><p>Stable </p><p>continue diabetes medications</p><p>continue statin</p><p>discussed yearly retinal exam</p><p>educated daily foot care, inspection and red flags</p><p>encouraged lifestyle modifications</p><p>monitor labs periodically</p><p>continue to update immunizations</p></td><td/></tr><tr><td ID="ref3">05/10/2024</td><td>Hyperlipidemia, unspecified (ICD-10 - E78.5)</td><td>ICDCodeVersion: ICD 10 - WHO</td><td><p>stable</p><p>continue statin</p><p>encouraged lifestyle modifications</p><p>monitor labs</p></td><td/></tr><tr><td ID="ref4">05/10/2024</td><td>Chronic pulmonary embolism (ICD-10 - I27.82)</td><td>she has a PE on april 2022 . Currently on long term anticoagulation therapy with Eliquis.</td><td>on eloquis BID </td><td/></tr><tr><td ID="ref5">05/10/2024</td><td>Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or chronic kidney disease (ICD-10 - I13.0)</td><td/><td><p>at goal</p><p>continue current BP meds</p><p>advised lifestyle modifications</p><p>advised normal BP range and to reach out if BP is elevated above normal range</p></td><td/></tr><tr><td ID="ref6">05/10/2024</td><td>Stage 3b chronic kidney disease (ICD-10 - N18.32)</td><td/><td><p>The main goal of treatment is to prevent the progression of CKD to complete kidney failure</p><p>BP control advised</p><p>Dietary changes, including protein restrictions</p><p>Lab (Egfr, creatinine, albuminuria) values on a frequent basis</p><p>Glycemic control</p><p>Avoid nephrotoxic drugs such as NSAIDs.</p></td><td/></tr><tr><td ID="ref7">05/10/2024</td><td>Acute on chronic right heart failure (ICD-10 - I50.813)</td><td/><td>Notes: Stable will monitor  </td><td/></tr><tr><td ID="ref8">05/10/2024</td><td>Type 2 diabetes mellitus with diabetic chronic kidney disease (ICD-10 - E11.22)</td><td/><td>Continue current medications. Check HgbA1C every 3 months. Encourage ADA, low carb diet and daily exercise. Eye and foot care reviewed.</td><td/></tr><tr><td ID="ref9">05/10/2024</td><td>Seasonal allergic rhinitis due to pollen (ICD-10 - J30.1)</td><td/><td>will do montelukast </td><td/></tr></tbody></table></div><h3><a name="id9" href="#toc">PLAN OF TREATMENT</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Atorvastatin Calcium 20 MG</td><td>1 tablet once a day for 90 days Oral Once a day for 90 days</td><td>11/14/2023</td><td/><td/></tr><tr><td ID="potMeds2">Lisinopril 20 MG</td><td>1 tablet Orally Once a day for 90 days</td><td>11/14/2023</td><td/><td/></tr><tr><td ID="potMeds3">metFORMIN HCl 500 MG</td><td>1 tablet with a meal Orally twice a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds4">Montelukast Sodium 10 MG</td><td>1 tablet Orally Once a day for 30 days</td><td>05/10/2024</td><td/><td/></tr></tbody></table><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">Type 2 diabetes mellitus with diabetic polyneuropathy</td><td>Continue current medications. Check HgbA1C every 3 months. Encourage ADA, low carb diet and daily exercise. Eye and foot care reviewed.</td></tr><tr><td ID="instructionpot2">Type 2 diabetes mellitus with hyperglycemia</td><td><p>Stable </p><p>continue diabetes medications</p><p>continue statin</p><p>discussed yearly retinal exam</p><p>educated daily foot care, inspection and red flags</p><p>encouraged lifestyle modifications</p><p>monitor labs periodically</p><p>continue to update immunizations</p></td></tr><tr><td ID="instructionpot3">Hyperlipidemia, unspecified</td><td><p>stable</p><p>continue statin</p><p>encouraged lifestyle modifications</p><p>monitor labs</p></td></tr><tr><td ID="instructionpot4">Chronic pulmonary embolism</td><td>on eloquis BID </td></tr><tr><td ID="instructionpot5">Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or chronic kidney disease</td><td><p>at goal</p><p>continue current BP meds</p><p>advised lifestyle modifications</p><p>advised normal BP range and to reach out if BP is elevated above normal range</p></td></tr><tr><td ID="instructionpot6">Stage 3b chronic kidney disease</td><td><p>The main goal of treatment is to prevent the progression of CKD to complete kidney failure</p><p>BP control advised</p><p>Dietary changes, including protein restrictions</p><p>Lab (Egfr, creatinine, albuminuria) values on a frequent basis</p><p>Glycemic control</p><p>Avoid nephrotoxic drugs such as NSAIDs.</p></td></tr><tr><td ID="instructionpot7">Acute on chronic right heart failure</td><td>Notes: Stable will monitor  </td></tr><tr><td ID="instructionpot8">Type 2 diabetes mellitus with diabetic chronic kidney disease</td><td>Continue current medications. Check HgbA1C every 3 months. Encourage ADA, low carb diet and daily exercise. Eye and foot care reviewed.</td></tr><tr><td ID="instructionpot9">Seasonal allergic rhinitis due to pollen</td><td>will do montelukast </td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 4 Weeks, Reason: </td></tr><tr><td ID="futureAppt1">Provider Name:Mariam Cabrera, 08/22/2024 01:00:00 PM, 1806 N PINE ISLAND RD, PLANTATION, FL, 33322-5202, 954-474-0110</td></tr></tbody></table></div><h3><a name="id10" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>AARON, PELAT <span class="bold">DOB:</span> 09/04/1934 (89 yo F) <span class="bold">Acc No.</span> 71937 <span class="bold">DOS:</span> 05/10/2024</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold">Progress Notes</span></td></tr><tr><td align="left"><span class="bold">Patient: </span>AARON, PELAT<br/><span class="bold">Account Number: </span>71937</td><td align="right"><span class="bold">Provider: </span>GLENDA BUYO, MD</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>09/04/1934<span class="bold">   Age: </span>89 Y<span class="bold">   Sex: </span>Female</td><td align="right"><span class="bold">Date: </span>05/10/2024</td></tr><tr><td><span class="bold">Phone: </span>305-522-8974</td></tr><tr><td colspan="2"><span class="bold">Address: </span>19520 NW 37TH AVENUE, MIAMI GARDENS, FL-33056</td></tr><tr><td colspan="2"><span class="bold">Structured Data: </span> MRA Deep Review Date : 04/01/2024; MRA- QR Review Date : 05/09/2024</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   1. PT. FOLLOW UP. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">General</span>: <br/>       Provider HPI:.<br/>       Pt is an 87      yrs old coming in today for follow up  She has DM2, HTN, PE . <br/>       She has not been taking metformin-- Her A1c is 9.2 <br/>       Also does not have lisinopril <br/>       She lives at home with son Darryl went over all the medications. - Advised to check glucose daily. <br/>       Before, having PE she was walking and since discharged from hospital has been on wheelchair. She does not have strength to get up and go. Her knees feel weak. <br/>       She cannot bathe herself and needs assistance. Cannot use bathroom on her own and now wears depends pads. <br/>       She has developed a small lesion on her buttocks.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   <span class="Underline">General / Constitutional</span>: <br/>      Patient denies change in appetite, chills, fatigue.   <br/>   <span class="Underline">Respiratory</span>: <br/>      Patient denies chronic cough, shortness of breath, wheezing.   <br/>   <span class="Underline">Cardiovascular</span>: <br/>      Patient denies chest pain, palpitations, shortness of breath.   <br/>   </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> Medical History Verified.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   <span class="Underline">Drugs/Alcohol:</span> <br/>       Drugs <br/>         Have you used drugs other than those for medical reasons in the past 12 months? <span class="italics">No</span><br/>      Alcohol Screen (Audit-C) <br/>         Did you have a drink containing alcohol in the past year? <span class="italics">No</span><br/>         Points <span class="italics">0</span><br/>         Interpretation <span class="italics">Negative</span><br/>      Caffeine <br/>         Intake: <span class="italics">none</span><br/>      Do you smoke marijuana?: DENIES. <br/>      Do you drink alcohol?: Non-drinker. </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> Taking Lisinopril 20 MG Tablet 1 tablet Orally Once a day , Taking metFORMIN HCl 500 MG Tablet 1 tablet with a meal Orally twice a day , Taking hydroCHLOROthiazide 12.5 MG Capsule TAKE 1 CAPSULE BY MOUTH EVERY DAY IN THE MORNING   , Taking Eliquis 5 MG Tablet TAKE 1 TABLET BY MOUTH TWICE DAILY   , Taking Atorvastatin Calcium 20 MG Tablet 1 tablet once a day for 90 days Oral Once a day , Taking Vitamin D3 1.25 MG (50000 UT) Capsule 1 capsule Orally once a week , stop date 07/03/2024</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> N.K.D.A.</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> Temp: <span class="bold">97.2</span> F, HR: <span class="bold">93</span> /min, BP: <span class="bold">130/90</span> mm Hg, Ht: 63 in, Pain scale: <span class="bold">0</span> 1-10, Blood Glucose Test (Capillary): 164, Oxygen sat %: <span class="bold">99</span> %, RR: <span class="bold">18</span> /min, Ht-cm: 160.02 cm.</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td><span class="bold">   Past Orders:</span></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:Thyroid Panel With TSH-000620 (Order Date - 04/03/2024) (Collection Date &amp; Time - 04/03/2024)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        TSH</td><td align="left">0.539</td><td align="left"/><td align="left">0.450-4.500 - uIU/mL</td></tr><tr><td align="left">        Thyroxine (T4)</td><td align="left">7.9</td><td align="left"/><td align="left">4.5-12.0 - ug/dL</td></tr><tr><td align="left">        T3 Uptake</td><td align="left">28</td><td align="left"/><td align="left">24-39 - %</td></tr><tr><td align="left">        Free Thyroxine Index</td><td align="left">2.2</td><td align="left"/><td align="left">1.2-4.9 - </td></tr><tr><td colspan="4"><span class="content_span">        Notes: Pough, Cassandra 4/4/2024 04:37:30 PM &gt; PT. NOTIFIED AND UNDERSTOOD RESULTS, SENT MED TO PHARM ON FILE PT. NOTIFIED AND UNDERSTOOD RESULTS, SENT MED TO PHARM ON FILE Pough, Cassandra 4/4/2024 04:37:25 PM &gt;</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:Vitamin B12 and Folate-000810 (Order Date - 04/03/2024) (Collection Date &amp; Time - 04/03/2024)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        Vitamin B12</td><td align="left">394</td><td align="left"/><td align="left">232-1245 - pg/mL</td></tr><tr><td align="left">        Folate (Folic Acid), Serum</td><td align="left">10.0</td><td align="left"/><td align="left">&gt;3.0 - ng/mL</td></tr><tr><td colspan="4"><span class="content_span">        Notes: PT. NOTIFIED AND UNDERSTOOD RESULTS, SENT MED TO PHARM ON FILE Pough, Cassandra 4/4/2024 04:37:25 PM &gt;</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:Hemoglobin A1c-001453 (Order Date - 04/03/2024) (Collection Date &amp; Time - 04/03/2024)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        Hemoglobin A1c</td><td align="left">9.2</td><td align="left">H</td><td align="left">4.8-5.6 - %</td></tr><tr><td colspan="4"><span class="content_span">        Notes: PT. NOTIFIED AND UNDERSTOOD RESULTS, SENT MED TO PHARM ON FILE Pough, Cassandra 4/4/2024 04:37:25 PM &gt;</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:CBC With Differential/Platelet-005009 (Order Date - 04/03/2024) (Collection Date &amp; Time - 04/03/2024)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        WBC</td><td align="left">6.5</td><td align="left"/><td align="left">3.4-10.8 - x10E3/uL</td></tr><tr><td align="left">        RBC</td><td align="left">4.36</td><td align="left"/><td align="left">3.77-5.28 - x10E6/uL</td></tr><tr><td align="left">        Hemoglobin</td><td align="left">11.5</td><td align="left"/><td align="left">11.1-15.9 - g/dL</td></tr><tr><td align="left">        Hematocrit</td><td align="left">35.1</td><td align="left"/><td align="left">34.0-46.6 - %</td></tr><tr><td align="left">        MCV</td><td align="left">81</td><td align="left"/><td align="left">79-97 - fL</td></tr><tr><td align="left">        MCH</td><td align="left">26.4</td><td align="left">L</td><td align="left">26.6-33.0 - pg</td></tr><tr><td align="left">        MCHC</td><td align="left">32.8</td><td align="left"/><td align="left">31.5-35.7 - g/dL</td></tr><tr><td align="left">        RDW</td><td align="left">15.0</td><td align="left"/><td align="left">11.7-15.4 - %</td></tr><tr><td align="left">        Platelets</td><td align="left">289</td><td align="left"/><td align="left">150-450 - x10E3/uL</td></tr><tr><td align="left">        Neutrophils</td><td align="left">54</td><td align="left"/><td align="left">Not Estab. - %</td></tr><tr><td align="left">        Lymphs</td><td align="left">32</td><td align="left"/><td align="left">Not Estab. - %</td></tr><tr><td align="left">        Monocytes</td><td align="left">8</td><td align="left"/><td align="left">Not Estab. - %</td></tr><tr><td align="left">        Eos</td><td align="left">5</td><td align="left"/><td align="left">Not Estab. - %</td></tr><tr><td align="left">        Basos</td><td align="left">1</td><td align="left"/><td align="left">Not Estab. - %</td></tr><tr><td align="left">        Neutrophils (Absolute)</td><td align="left">3.6</td><td align="left"/><td align="left">1.4-7.0 - x10E3/uL</td></tr><tr><td align="left">        Lymphs (Absolute)</td><td align="left">2.1</td><td align="left"/><td align="left">0.7-3.1 - x10E3/uL</td></tr><tr><td align="left">        Monocytes(Absolute)</td><td align="left">0.5</td><td align="left"/><td align="left">0.1-0.9 - x10E3/uL</td></tr><tr><td align="left">        Eos (Absolute)</td><td align="left">0.3</td><td align="left"/><td align="left">0.0-0.4 - x10E3/uL</td></tr><tr><td align="left">        Baso (Absolute)</td><td align="left">0.0</td><td align="left"/><td align="left">0.0-0.2 - x10E3/uL</td></tr><tr><td align="left">        Immature Granulocytes</td><td align="left">0</td><td align="left"/><td align="left">Not Estab. - %</td></tr><tr><td align="left">        Immature Grans (Abs)</td><td align="left">0.0</td><td align="left"/><td align="left">0.0-0.1 - x10E3/uL</td></tr><tr><td colspan="4"><span class="content_span">        Notes: PT. NOTIFIED AND UNDERSTOOD RESULTS, SENT MED TO PHARM ON FILE Pough, Cassandra 4/4/2024 04:37:25 PM &gt;</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:Lipid Panel With LDL/HDL Ratio-235010 (Order Date - 04/03/2024) (Collection Date &amp; Time - 04/03/2024)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        Cholesterol, Total</td><td align="left">110</td><td align="left"/><td align="left">100-199 - mg/dL</td></tr><tr><td align="left">        Triglycerides</td><td align="left">61</td><td align="left"/><td align="left">0-149 - mg/dL</td></tr><tr><td align="left">        HDL Cholesterol</td><td align="left">43</td><td align="left"/><td align="left">&gt;39 - mg/dL</td></tr><tr><td align="left">        VLDL Cholesterol Cal</td><td align="left">13</td><td align="left"/><td align="left">5-40 - mg/dL</td></tr><tr><td align="left">        LDL Chol Calc (NIH)</td><td align="left">54</td><td align="left"/><td align="left">0-99 - mg/dL</td></tr><tr><td align="left">        LDL/HDL Ratio</td><td align="left">1.3</td><td align="left"/><td align="left">0.0-3.2 - ratio</td></tr><tr><td colspan="4"><span class="content_span">        Notes: PT. NOTIFIED AND UNDERSTOOD RESULTS, SENT MED TO PHARM ON FILE Pough, Cassandra 4/4/2024 04:37:25 PM &gt;</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:Comp. Metabolic Panel (14)-322000 (Order Date - 04/03/2024) (Collection Date &amp; Time - 04/03/2024)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        Glucose</td><td align="left">105</td><td align="left">H</td><td align="left">70-99 - mg/dL</td></tr><tr><td align="left">        BUN</td><td align="left">15</td><td align="left"/><td align="left">8-27 - mg/dL</td></tr><tr><td align="left">        Creatinine</td><td align="left">1.18</td><td align="left">H</td><td align="left">0.57-1.00 - mg/dL</td></tr><tr><td align="left">        BUN/Creatinine Ratio</td><td align="left">13</td><td align="left"/><td align="left">12-28 - </td></tr><tr><td align="left">        Sodium</td><td align="left">139</td><td align="left"/><td align="left">134-144 - mmol/L</td></tr><tr><td align="left">        Potassium</td><td align="left">4.6</td><td align="left"/><td align="left">3.5-5.2 - mmol/L</td></tr><tr><td align="left">        Chloride</td><td align="left">102</td><td align="left"/><td align="left">96-106 - mmol/L</td></tr><tr><td align="left">        Carbon Dioxide, Total</td><td align="left">24</td><td align="left"/><td align="left">20-29 - mmol/L</td></tr><tr><td align="left">        Calcium</td><td align="left">9.4</td><td align="left"/><td align="left">8.7-10.3 - mg/dL</td></tr><tr><td align="left">        Protein, Total</td><td align="left">6.7</td><td align="left"/><td align="left">6.0-8.5 - g/dL</td></tr><tr><td align="left">        Albumin</td><td align="left">4.0</td><td align="left"/><td align="left">3.7-4.7 - g/dL</td></tr><tr><td align="left">        Globulin, Total</td><td align="left">2.7</td><td align="left"/><td align="left">1.5-4.5 - g/dL</td></tr><tr><td align="left">        A/G Ratio</td><td align="left">1.5</td><td align="left"/><td align="left">1.2-2.2 - </td></tr><tr><td align="left">        Bilirubin, Total</td><td align="left">0.4</td><td align="left"/><td align="left">0.0-1.2 - mg/dL</td></tr><tr><td align="left">        Alkaline Phosphatase</td><td align="left">89</td><td align="left"/><td align="left">44-121 - IU/L</td></tr><tr><td align="left">        AST (SGOT)</td><td align="left">17</td><td align="left"/><td align="left">0-40 - IU/L</td></tr><tr><td align="left">        ALT (SGPT)</td><td align="left">14</td><td align="left"/><td align="left">0-32 - IU/L</td></tr><tr><td align="left">        eGFR</td><td align="left">44</td><td align="left">L</td><td align="left">&gt;59 - mL/min/1.73</td></tr><tr><td colspan="4"><span class="content_span">        Notes: PT. NOTIFIED AND UNDERSTOOD RESULTS, SENT MED TO PHARM ON FILE Pough, Cassandra 4/4/2024 04:37:25 PM &gt;</span></td></tr><tr><td colspan="4"><br/></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:Vitamin D, 25-Hydroxy-081950 (Order Date - 04/03/2024) (Collection Date &amp; Time - 04/03/2024)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        Vitamin D, 25-Hydroxy</td><td align="left">12.1</td><td align="left">L</td><td align="left">30.0-100.0 - ng/mL</td></tr><tr><td colspan="4"><span class="content_span">        Notes: PT. NOTIFIED AND UNDERSTOOD RESULTS, SENT MED TO PHARM ON FILE Pough, Cassandra 4/4/2024 04:37:25 PM &gt;</span></td></tr><tr><td colspan="4"><br/></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">General Examination:</span><br/>      General appearance: alert, pleasant, no apparent distress, No acute distress, Well-groomed-- in wheelchair. <br/>      Throat: pharynx normal. <br/>      Skin: skin is warm and dry, with no rashes, good skin turgor and normal hair distribution. <br/>      Heart: regular rate and rhythm without murmurs, gallops, clicks or rubs. <br/>      Abdomen: soft with good bowel sounds, nontender, and no masses or hepatosplenomegaly, no hernias present.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. Type 2 diabetes mellitus with hyperglycemia - E11.65 (Primary) 2. Type 2 diabetes mellitus with diabetic polyneuropathy - E11.42 3. Hyperlipidemia, unspecified - E78.5, ICDCodeVersion: ICD 10 - WHO 4. Chronic pulmonary embolism - I27.82, she has a PE on april 2022 . Currently on long term anticoagulation therapy with Eliquis. 5. Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or chronic kidney disease - I13.0 6. Stage 3b chronic kidney disease - N18.32 7. Acute on chronic right heart failure - I50.813 8. Type 2 diabetes mellitus with diabetic chronic kidney disease - E11.22 9. Seasonal allergic rhinitis due to pollen - J30.1 </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. Type 2 diabetes mellitus with hyperglycemia</span> <br/>Notes: Stable <br/>continue diabetes medications<br/>continue statin<br/>discussed yearly retinal exam<br/>educated daily foot care, inspection and red flags<br/>encouraged lifestyle modifications<br/>monitor labs periodically<br/>continue to update immunizations  </td></tr><tr><td/></tr><tr><td><span class="bold">2. Type 2 diabetes mellitus with diabetic polyneuropathy</span> <br/>Refill metFORMIN HCl Tablet, 500 MG, 1 tablet with a meal, Orally, twice a day, 90 days, 180, Refills 0; Start Montelukast Sodium Tablet, 10 MG, 1 tablet, Orally, Once a day, 30 days, 30, Refills 1; Refill Atorvastatin Calcium Tablet, 20 MG, 1 tablet once a day for 90 days, Oral, Once a day, 90 days, 90, Refills 0.  <br/>Notes: Continue current medications. Check HgbA1C every 3 months. Encourage ADA, low carb diet and daily exercise. Eye and foot care reviewed.  </td></tr><tr><td/></tr><tr><td><span class="bold">3. Hyperlipidemia, unspecified</span> <br/>Notes: stable<br/>continue statin<br/>encouraged lifestyle modifications<br/>monitor labs  </td></tr><tr><td/></tr><tr><td><span class="bold">4. Chronic pulmonary embolism</span> <br/>Notes: on eloquis BID   </td></tr><tr><td/></tr><tr><td><span class="bold">5. Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or chronic kidney disease</span> <br/>Notes: at goal<br/>continue current BP meds<br/>advised lifestyle modifications<br/>advised normal BP range and to reach out if BP is elevated above normal range  </td></tr><tr><td/></tr><tr><td><span class="bold">6. Stage 3b chronic kidney disease</span> <br/>Notes: The main goal of treatment is to prevent the progression of CKD to complete kidney failure<br/>BP control advised<br/>Dietary changes, including protein restrictions<br/>Lab (Egfr, creatinine, albuminuria) values on a frequent basis<br/>Glycemic control<br/>Avoid nephrotoxic drugs such as NSAIDs.  </td></tr><tr><td/></tr><tr><td><span class="bold">7. Acute on chronic right heart failure</span> <br/>Notes: <span class="content_span">Notes: Stable will monitor  </span>  </td></tr><tr><td/></tr><tr><td><span class="bold">8. Type 2 diabetes mellitus with diabetic chronic kidney disease</span> <br/>Notes: Continue current medications. Check HgbA1C every 3 months. Encourage ADA, low carb diet and daily exercise. Eye and foot care reviewed.  </td></tr><tr><td/></tr><tr><td><span class="bold">9. Seasonal allergic rhinitis due to pollen</span> <br/>Notes: will do montelukast   </td></tr><tr><td/></tr><tr><td><span class="bold">10. Others </span> <br/>Refill Lisinopril Tablet, 20 MG, 1 tablet, Orally, Once a day, 90 days, 90, Refills 0.  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Recommended Wellness and Prevention Guidelines: </span></td></tr></tbody></table></li></ul><ul><li><table border="1"><tbody><tr><td colspan=""> Status</td><td colspan=""> Alert</td><td colspan=""> Last Done</td><td colspan=""> Next Due</td><td colspan=""> Action Taken</td></tr><tr><td colspan=""> COMPLIANT</td><td colspan=""> Care of Older Adult- Medication Reconciliation</td><td colspan=""> 05/10/2024 </td><td colspan=""> 05/10/2025</td><td colspan=""> Documented structured data - Date of last Medication Review:</td></tr><tr><td colspan=""> COMPLIANT</td><td colspan=""> Care of Older Adult- Pain Screening</td><td colspan=""> 05/10/2024 </td><td colspan=""> 05/10/2025</td><td colspan=""> Documented structured data - Date of last Pain Assessment:</td></tr><tr><td colspan=""> COMPLIANT</td><td colspan=""> Care of Older Adult: Advanced Care Planning</td><td colspan=""> 04/10/2024 </td><td colspan=""> 04/10/2025</td><td colspan=""> Documented structured data - Date of last Advance Care Planning:</td></tr><tr><td colspan=""> COMPLIANT</td><td colspan=""> Care of Older Adult: Functional Status Assessment</td><td colspan=""> 04/03/2024 </td><td colspan=""> 04/03/2025</td><td colspan=""> Documented structured data - Date of last completed Functional Status Assessment:</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 3075F SYST BP GE 130 - 139MM HG, 3080F DIAST BP &gt;/= 90 MM HG, 1126F AMNT PAIN NOTED NONE PRSNT, 3046F HEMOGLOBIN A1C LEVEL &gt;9.0%</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Preventive Medicine:</span> <br/>  QUALITY: <br/>       HEDIS Measures <br/>          Screening: <span class="italics">No falls in the past year</span><br/>          Date of last completed Functional Status Assessment: <span class="italics">04/03/2024</span><br/>          Functional Status <span class="italics">Cannot walk 200 feet with assistance devide (cane or crutch)</span><br/>          Date of last Pain Assessment: <span class="italics">05/10/2024</span><br/>          Date of last Medication Review: <span class="italics">05/10/2024</span><br/>          Date of last Advance Care Planning: <span class="italics">04/10/2024</span><br/>          Last done FOBT <span class="italics"> Aged Out of Measure</span><br/>          Most Recent HbA1c (Less then 9.0) <span class="italics">Uncontrolled</span><br/>          Value <span class="italics">9.2</span><br/>          Date of Result <span class="italics">04/10/2024</span><br/>          KED (eGFR &amp; uACR) <span class="italics">Resulted Together</span><br/>          PHQ9 <span class="italics">04/10/2024</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 4 Weeks</td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99214 Office Visit, Est Pt., Level 4.  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> <br/>3075F SYST BP GE 130 - 139MM HG. <br/>3080F DIAST BP &gt;/= 90 MM HG. <br/>1126F AMNT PAIN NOTED NONE PRSNT. <br/>3046F HEMOGLOBIN A1C LEVEL &gt;9.0%. </td></tr></tbody></table></li></ul><br/><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top">Electronically signed by GLENDA BUYO , MD  on 05/29/2024 at 09:00 AM EDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> GLENDA BUYO, MD</td><td align="right"><span class="bold">Date: </span>05/10/2024</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id11" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="5">General Examination</td><td>General appearance:</td><td colspan="2">alert, pleasant, no apparent distress, No acute distress, Well-groomed-- in wheelchair</td></tr><tr><td>Throat:</td><td colspan="2">pharynx normal</td></tr><tr><td>Heart:</td><td colspan="2">regular rate and rhythm without murmurs, gallops, clicks or rubs</td></tr><tr><td>Abdomen:</td><td colspan="2">soft with good bowel sounds, nontender, and no masses or hepatosplenomegaly, no hernias present</td></tr><tr><td>Skin:</td><td colspan="2">skin is warm and dry, with no rashes, good skin turgor and normal hair distribution</td></tr></tbody></table><br/></li></ul></div><br/><br/></body></html>